.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Argus Health
Chubb
Cipla
US Department of Justice
Express Scripts
Cantor Fitzgerald
Boehringer Ingelheim
Dow

Generated: December 18, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: rufinamide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai IncBANZELrufinamideSUSPENSION;ORAL201367NDAEisai Inc.62856-584-461 BOTTLE in 1 CARTON (62856-584-46) > 460 mL in 1 BOTTLE
Eisai IncBANZELrufinamideTABLET;ORAL021911NDAEisai Inc.62856-582-52120 TABLET, FILM COATED in 1 BOTTLE (62856-582-52)
Eisai IncBANZELrufinamideTABLET;ORAL021911NDAEisai Inc.62856-583-52120 TABLET, FILM COATED in 1 BOTTLE (62856-583-52)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Merck
Chubb
Mallinckrodt
McKesson
UBS
Cerilliant
Novartis
US Department of Justice

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot